A new study published today reveals systematic biases among primary and HIV care providers about people who inject drugs and how those biases may impact access to pre-exposure prophylaxis (PrEP), a preventive, prescription-based medication that significantly reduces the risk of HIV infection through sexual behavior and injection practices. The study was led by Sarah Calabrese, an assistant professor of clinical psychology at GW.
New Study Suggests Healthcare Provider Biases Can Impact a Patient’s Access to Preventative HIV Drug
November 9, 2021